Noreen Henig
Directeur/Membre du Conseil chez AVIDITY BIOSCIENCES, INC.
Fortune : 11 794 $ au 30/04/2024
Postes actifs de Noreen Henig
Sociétés | Poste | Début | Fin |
---|---|---|---|
AVIDITY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 22/08/2019 | - |
Independent Dir/Board Member | 22/08/2019 | - | |
LAZARD GROWTH ACQUISITION CORP. I | Directeur/Membre du Conseil | 09/02/2021 | - |
Independent Dir/Board Member | 09/02/2021 | - | |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - |
Historique de carrière de Noreen Henig
Anciens postes connus de Noreen Henig
Sociétés | Poste | Début | Fin |
---|---|---|---|
KEZAR LIFE SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 04/05/2020 | 06/10/2023 |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Directeur Technique/Scientifique/R&D | 01/07/2018 | 01/03/2020 |
PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/03/2014 | 01/12/2017 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2008 | 01/01/2014 |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1999 | 01/01/2008 |
Formation de Noreen Henig
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Yale University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Pays-Bas | 2 |
Allemagne | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
AVIDITY BIOSCIENCES, INC. | Health Technology |
KEZAR LIFE SCIENCES, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Health Services |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Health Technology |
Lazard Growth Acquisition Corp. I
Lazard Growth Acquisition Corp. I SemiconductorsElectronic Technology Lazard Growth Acquisition Corp. I operates as a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. The company was founded on December 10, 2020 and is headquartered in New York, NY. | Electronic Technology |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Finance |
- Bourse
- Insiders
- Noreen Henig
- Expérience